Up a level |
Number of items: 1.
McWilliam, SJ ORCID: 0000-0002-0509-7425, Antoine, DJ, Rosala-Hallas, A ORCID: 0000-0001-8012-9995, Jones, A, MacLean, C, Prayle, A, Smyth, AR, Flaherty, L, Shaw, VE, Greenhalf, W et al (show 2 more authors)
(2017)
THE PROTEKT STUDY - A PHASE IIA, RANDOMISED, CONTROLLED, OPEN-LABEL TRIAL OF ROSUVASTATIN FOR THE PREVENTION OF AMINOGLYCOSIDE-INDUCED KIDNEY TOXICITY IN CHILDREN WITH CYSTIC FIBROSIS.
In: 31st Annual North American Cystic Fibrosis Conference, 2017-11-2 - 2017-11-4, Indiana Convention Center, Indianapolis, Indiana.